# Immunome Inc.: filings

IMNM · Nasdaq · CIK 1472012 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/imnm.md) · [Financials](/companies/imnm/financials.md) · [Filings](/companies/imnm/filings.md) · [Insiders](/companies/imnm/insiders.md)

## Reports and events: 124 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 156, 8-K 82, 3 30, 10-Q 18, 144 17, SCHEDULE 13G/A 14, D 13, SC 13G/A 13, SC 13G 11, 424B5 8, CORRESP 8, D/A 7, 10-K 6, DEF 14A 6, DEFA14A 6, S-8 6, EFFECT 5, S-3ASR 5, SCHEDULE 13G 5, UPLOAD 5, 425 4, ARS 4, S-1/A 3, SC 13D 3, S-1 2, S-3 2, SCHEDULE 13D/A 2, SEC STAFF LETTER 2, 144/A 1, 3/A 1, 424B3 1, 424B4 1, 8-A12B 1, 8-K/A 1, CERT 1, DRS 1, PRE 14A 1, S-1MEF 1, S-4 1, S-4/A 1, S-8 POS 1, SC 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-05 | 08:30 ET | [8-K](/filings/0001193125-26-413217.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-413217 |
| 2026-08-11 | 16:10 ET | [10-Q](/filings/0001193125-26-344636.md) | Quarterly report, period 2026-06-30 | 0001193125-26-344636 |
| 2026-08-11 | 16:05 ET | [8-K](/filings/0001193125-26-344577.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-344577 |
| 2026-06-12 | 16:05 ET | [8-K](/filings/0001193125-26-269383.md) | 5.07 Shareholder vote results | 0001193125-26-269383 |
| 2026-05-12 | 16:10 ET | [10-Q](/filings/0001193125-26-219425.md) | Quarterly report, period 2026-03-31 | 0001193125-26-219425 |
| 2026-05-12 | 16:05 ET | [8-K](/filings/0001193125-26-219367.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-219367 |
| 2026-04-24 | 16:05 ET | [DEF 14A](/filings/0001140361-26-016685.md) | Proxy statement, period 2026-06-09 | 0001140361-26-016685 |
| 2026-03-03 | 16:07 ET | [10-K](/filings/0001193125-26-088172.md) | Annual report, period 2025-12-31 | 0001193125-26-088172 |
| 2026-03-03 | 16:05 ET | [8-K](/filings/0001193125-26-088141.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-088141 |
| 2025-12-22 | 21:22 ET | [SCHEDULE 13D/A](/filings/0001953107-25-000019.md) | Ownership report, active investor, amended | 0001953107-25-000019 |
| 2025-12-17 | 16:49 ET | [8-K](/filings/0001193125-25-322877.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-322877 |
| 2025-12-15 | 07:05 ET | [8-K](/filings/0001193125-25-318429.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-318429 |
| 2025-11-06 | 16:18 ET | [10-Q](/filings/0001193125-25-269603.md) | Quarterly report, period 2025-09-30 | 0001193125-25-269603 |
| 2025-11-06 | 16:12 ET | [8-K](/filings/0001193125-25-269538.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-269538 |
| 2025-08-06 | 16:12 ET | [10-Q](/filings/0000950170-25-104035.md) | Quarterly report, period 2025-06-30 | 0000950170-25-104035 |
| 2025-08-06 | 16:10 ET | [8-K](/filings/0000950170-25-104015.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-104015 |
| 2025-06-11 | 16:01 ET | [8-K](/filings/0001104659-25-058523.md) | 5.07 Shareholder vote results | 0001104659-25-058523 |
| 2025-05-12 | 16:12 ET | [10-Q](/filings/0001558370-25-007382.md) | Quarterly report, period 2025-03-31 | 0001558370-25-007382 |
| 2025-05-12 | 16:10 ET | [8-K](/filings/0001104659-25-047304.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-047304 |
| 2025-04-24 | 16:05 ET | [DEF 14A](/filings/0001140361-25-015421.md) | Proxy statement, period 2025-06-10 | 0001140361-25-015421 |
| 2025-03-19 | 16:11 ET | [10-K](/filings/0001558370-25-003302.md) | Annual report, period 2024-12-31 | 0001558370-25-003302 |
| 2025-03-19 | 16:08 ET | [8-K](/filings/0001104659-25-025558.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-025558 |
| 2025-02-04 | 17:44 ET | [SCHEDULE 13D/A](/filings/0001415889-25-002988.md) | Ownership report, active investor, amended | 0001415889-25-002988 |
| 2025-01-30 | 16:28 ET | [8-K](/filings/0001104659-25-007610.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-007610 |
| 2025-01-29 | 16:03 ET | [8-K](/filings/0001104659-25-007198.md) | 2.02 Results of operations; 8.01 Other events | 0001104659-25-007198 |
| 2025-01-23 | 16:01 ET | [8-K](/filings/0001104659-25-005594.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-005594 |
| 2024-11-13 | 16:10 ET | [10-Q](/filings/0001558370-24-015524.md) | Quarterly report, period 2024-09-30 | 0001558370-24-015524 |
| 2024-11-13 | 16:06 ET | [8-K](/filings/0001104659-24-117682.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-117682 |
| 2024-10-29 | 08:05 ET | [8-K](/filings/0001104659-24-112053.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-24-112053 |
| 2024-10-08 | 19:14 ET | [8-K](/filings/0001104659-24-106777.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-106777 |
| 2024-08-21 | 16:05 ET | [SC 13D/A](/filings/0001123292-24-000228.md) | Ownership report, active investor, amended | 0001123292-24-000228 |
| 2024-08-12 | 16:10 ET | [10-Q](/filings/0001558370-24-011898.md) | Quarterly report, period 2024-06-30 | 0001558370-24-011898 |
| 2024-08-12 | 16:05 ET | [8-K](/filings/0001104659-24-088340.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-088340 |
| 2024-06-13 | 16:05 ET | [8-K](/filings/0001104659-24-071253.md) | 5.07 Shareholder vote results | 0001104659-24-071253 |
| 2024-05-14 | 08:05 ET | [10-Q](/filings/0001558370-24-008066.md) | Quarterly report, period 2024-03-31 | 0001558370-24-008066 |
| 2024-05-14 | 08:02 ET | [8-K](/filings/0001104659-24-060893.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-060893 |
| 2024-04-30 | 16:01 ET | [8-K](/filings/0001104659-24-054910.md) | 5.02 Departure or appointment of officers or directors | 0001104659-24-054910 |
| 2024-04-26 | 16:05 ET | [DEF 14A](/filings/0001140361-24-022426.md) | Proxy statement, period 2024-06-12 | 0001140361-24-022426 |
| 2024-04-25 | 16:01 ET | [8-K](/filings/0001104659-24-051944.md) | 5.02 Departure or appointment of officers or directors | 0001104659-24-051944 |
| 2024-03-28 | 16:06 ET | [10-K](/filings/0001558370-24-004247.md) | Annual report, period 2023-12-31 | 0001558370-24-004247 |
| 2024-03-28 | 16:04 ET | [8-K](/filings/0001104659-24-040503.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-040503 |
| 2024-03-26 | 08:05 ET | [8-K](/filings/0001104659-24-038744.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-038744 |
| 2024-02-14 | 16:11 ET | [8-K](/filings/0001104659-24-023641.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-023641 |
| 2024-02-13 | 16:10 ET | [8-K](/filings/0001104659-24-019883.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-019883 |
| 2024-02-06 | 08:05 ET | [8-K](/filings/0001104659-24-010945.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-010945 |
| 2024-02-01 | 21:18 ET | [8-K](/filings/0001104659-24-009012.md) | 5.02 Departure or appointment of officers or directors | 0001104659-24-009012 |
| 2024-01-11 | 17:27 ET | [8-K](/filings/0001104659-24-003380.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-003380 |
| 2024-01-08 | 07:05 ET | [8-K](/filings/0001104659-24-002059.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-24-002059 |
| 2024-01-02 | 08:05 ET | [8-K](/filings/0001104659-24-000121.md) | 5.02 Departure or appointment of officers or directors | 0001104659-24-000121 |
| 2023-12-29 | 17:00 ET | [8-K](/filings/0001104659-23-130516.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-23-130516 |

Page 1 of 3. [Older](/companies/imnm/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 12:06 ET. No prices; not investment advice.